Infection and associated factors in children and adolescents undergoing antineoplastic chemotherapy
DOI:
https://doi.org/10.21527/2176-7114.2024.48.14705Keywords:
Infections, Neoplasms, Child Health, Adolescent HealthAbstract
Objective: To evaluate the infection prevalence in children and adolescents with cancer undergoing chemotherapy and identify the associated factors. Methods: This cross-sectional study reviewed 59 medical records of children and adolescents with cancer receiving chemotherapy in the pediatric oncology ward at a referral center in Campina Grande, Paraíba. We conducted descriptive and multivariate analyses using Poisson regression. Results: The study identified a 47.5% infection prevalence during the first cycle of chemotherapy in children and adolescents with cancer. Significant risk factors for infection included invasive ventilation, non-invasive ventilation, and corticosteroid use. Significant symptoms and signs included diarrhea, adventitious sounds, dyspnea, headache, altered mental and behavioral states, fever, tachypnea, hepatomegaly, and splenomegaly. Conclusion: We found a high infection prevalence during the first cycle of chemotherapy. This complication can delay cancer treatment, promote tumor growth, and reduce the effectiveness of the therapy used.
References
1 Vliora C, Papadakis V, Doganis D, Tourkantoni N, Paisiou A, Kottaridi C, et al. A prospective study on the epidemiology and clinical significance of viral respiratory infections among pediatric oncology patients. Pediatr Hematol Oncol. 3 abr. 2019;36(3):173-186.
2 Whittle SB, Williamson KC, Russell HV. Incidence and Risk Factors of Bacterial and Fungal Infection During Induction Chemotherapy for High-Risk Neuroblastoma. Pediatr Hematol Oncol. ago. 2017;34(5):331-342.
3 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
4 Huesca IM, Vargas EP, Cruz MM da. Proteção social brasileira e demandas no tratamento oncológico infantojuvenil. Ciênc Saúde Coletiva. nov. 2018;23:3.965-3.978.
5 Estimativa 2020: incidência de câncer no Brasil [Internet]. Inca – Instituto Nacional de Câncer. 2019 [citado 19 abr. 2022]. Disponível em: https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil
6 Mutti CF, Cruz VG da, Santos LF, Araújo D de, Cogo SB, Neves ET. Perfil clínico-epidemiológico de Crianças e adolescentes com câncer em um serviço de oncologia. Rev Bras Cancerol. 28 de setembro de 2018;64(3):293-300.
7 ABC do Câncer. Abordagens Básicas para o controle do câncer [Internet]. Inca – Instituto Nacional de Câncer. 2020 [citado 21 abr. 2022]. Disponível em: https://www.inca.gov.br/publicacoes/livros/abc-do-cancer-abordagens-basicas-para-o-controle-do-cancer
8 Corrêa FE, Alves MK. Quimioterapia: Efeitos colaterais e influência no estado nutricional de pacientes oncológicos. Uniciências. 30 dez. 2018;22(2):100-105.
9 Silva SEM, Silva IB. Perfil das urgências onco-hematológicas em crianças e adolescentes atendidos em um hospital público de referência. Enferm Bras. 15 dez. 2017;16(5):293-302.
10 Hernández Orozco H, Lucas Resendiz E, Castañeda JL, De Colsa A, Ramirez Mayans J, Johnson KM, et al. Surveillance of healthcare associated infections in pediatric cancer patients between 2004 and 2009 in a public pediatric hospital in Mexico city, Mexico. J Pediatr Hematol Oncol. mar. 2014;36(2):96-98.
11 Martins RE. Avaliação do risco de complicações decorrentes de neutropenia febril em pacientes tratados no Instituto do Câncer do Estado de São Paulo [Internet] [text]. Universidade de São Paulo; 2014 [citado 19 abr. 2022]. Disponível em: http://www.teses.usp.br/teses/disponiveis/5/5155/tde-29102014-160517/
12 Brandi ACMB. Infecções fúngicas invasivas em crianças e adolescentes com câncer [Internet] [text]. Universidade de São Paulo; 2019 [citado 19 abr. 2022]. Disponível em: http://www.teses.usp.br/teses/disponiveis/5/5141/tde-09032020-104112/
13 Sinésio MCT, Magro MC da S, Carneiro TA, Da Silva KGN. Fatores de risco às infecções relacionadas à assistência em Unidades de Terapia Intensiva. Cogitare Enferm [Internet]. 23 maio 2018 [citado 19 abr. 2022];23(2). Disponível em: https://revistas.ufpr.br/cogitare/article/view/53826
14 Gupta A, Kapil A, Kabra SK, Lodha R, Sood S, Dhawan B, et al. Prospective study estimating healthcare associated infections in a paediatric hemato-oncology unit of a tertiary care hospital in north India. Indian J Med Res. dez. 2013;138(6):944-949.
15 Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, et al. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis. 23 maio 2008;8:70.
16 Alecrim RX, Taminato M, Belasco AGS, Barbosa D, Kusahara DM, Fram D. Boas práticas na prevenção de pneumonia associada à ventilação mecânica. Acta Paul Enferm. fev. 2019;32:11-17.
17 Rodrigues AN, Fragoso LV e C, Beserra F de M, Ramos IC. Impactos e fatores determinantes no bundle de pneumonia associada à ventilação mecânica. Rev Bras Enferm. dezembro de 2016;69(6):1.108-1.114.
18 Siqueira BS de S, Melo FG. Diarreia no paciente crítico: conhecimento e conduta de profissionais de unidades de terapia intensiva. Rev Enferm Contemp. 5 mar. 2021;10(1):33-42.
19 Thomsen M, Vitetta L. Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis. Integr Cancer Ther. dez. 2018;17(4):1.027-1.047.
20 Vallim L de B, Souza JB de, Alves R da S, Iunes DH, Chaves Érika de CL, Carvalho CC, et al. Análise correlacional durante e após os ciclos de quimioterapia com o perfil de ansiedade de pessoas com câncer. Cons. Saúde [Internet]. 14 jun. 2017 [citado 6 fev. 2025];16(1):124-130. Disponível em: https://periodicos.uninove.br/saude/article/view/6965
21 Sanchez-Codez MI, Rodríguez-Campoy, Estepa-Pedregosa L. Síndrome hemofagocítico: un simulador en un paciente con LAL-B en tratamiento con quimioterapia. Vox Paediatr 2019;26:19-21x
22 Larsen MK, Kofod T, Christiansen AE, Starch-Jensen T. Different Dosages of Corticosteroid and Routes of Administration in Mandibular Third Molar Surgery: a Systematic Review. J Oral Maxillofac Res. 29 jun. 2018;9(2):e1.
23 Lima MC, Pereira GR. Neutropenia febril: revisão da literatura em pacientes oncológicos. Rev Interdiscip Pensamento Científico [Internet]. 22 jul. 2017 [citado 19 abr. 2022];3(1). Disponível em: http://reinpeconline.com.br/index.php/reinpec/article/view/144
24 Reis DL dos A, Reis CA de S, Moia MY da S, Igreja PN, Borges RC de S, Júnior JRT de S, et al. Consulta sistematizada de enfermagem em quimioterapia antineoplásica. Braz J Dev. 17 fev. 2020;6(2):7.668-7.683.
25 Calegari IB, Cordeiro ALP de C, Stacciarini TSG, Ferreira LA. Diagnósticos de enfermagem em pacientes oncohematológicos submetidos a tratamento quimioterápico. Rev Enferm e Atenção À Saúde [Internet]. 2018 [citado 19 abr. 2022];7(3). Disponível em: https://seer.uftm.edu.br/revistaeletronica/index.php/enfer/article/view/3116
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Contexto & Saúde

This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.